| Announce Date | 08/07/2025 |
| EPS Normalized Actual | $3.53 (Beat by $0.05) |
| EPS GAAP Actual | $3.53 (Beat by $0.05) |
| Revenue Actual | $1.7191B |
| Revenue Surprise | Beat by $1719.1M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Mar 2030 | 22 | 14.76 | 21.37975 | 22.63043 | 1 |
| Mar 2030 | 20.31 | 15.99 | 19.85302 | 21.06745 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 3.6131 | 3.6131 | 1.7191B | 12.04% | 1719.1M |
| FQ1 2025 (Mar 2025) | 2.07 | 2.07 | 1.6973B | 7.62% | 1697.3M |
| FQ4 2024 (Dec 2024) | 4.76 | 4.76 | 2.1435B | 9.77% | 2143.5M |
| FQ3 2024 (Sep 2024) | 2.36 | 2.36 | 1.726B | 13.3% | 1726M |
| FQ2 2024 (Jun 2024) | 2.67 | 2.67 | 1.5122B | -1.89% | 1512.2M |
| FQ1 2024 (Mar 2024) | 1.41 | 1.41 | 1.5679B | 100% | 1567.9M |
| FQ4 2023 (Dec 2023) | 4.26 | 4.26 | 1.934B | 18.31% | 1934M |
| FQ3 2023 (Jul 2023) | 2 | 2 | 1.4965B | 100% | 1496.5M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 3.05 | -- | 2.99036 | 3.12887 | 7 |
| FQ4 2027 (Dec 2027) | 6.76 | -- | 6.62781 | 6.9348 | 5 |
| FQ3 2027 (Sep 2027) | 4.15 | -- | 4.06885 | 4.25731 | 3 |
| FQ2 2027 (Jun 2027) | 4.53 | -- | 4.44142 | 4.64714 | 3 |
| FQ1 2027 (Mar 2027) | 2.61 | -- | 2.55118 | 2.66935 | 6 |
| FQ4 2026 (Dec 2026) | 5.4 | -- | 5.27744 | 5.5219 | 6 |
| FQ3 2026 (Sep 2026) | 3.07 | -- | 3.00081 | 3.13981 | 6 |
| FQ2 2026 (Jun 2026) | 3.32 | -8.83 | 3.24517 | 3.39549 | 6 |
| FQ1 2026 (Mar 2026) | 2.29939 | 9.98 | 2.24757 | 2.35168 | 6 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 1.93B | -- | 1.9B | 1.97B | 6 |
| FQ4 2027 (Dec 2027) | 2.43B | -- | 2.39B | 2.48B | 6 |
| FQ3 2027 (Sep 2027) | 2.07B | -- | 2.04B | 2.11B | 4 |
| FQ2 2027 (Jun 2027) | 1.9B | -- | 1.87B | 1.94B | 4 |
| FQ1 2027 (Mar 2027) | 1.72B | -- | 1.69B | 1.75B | 5 |
| FQ4 2026 (Dec 2026) | 2.14B | -- | 2.11B | 2.18B | 4 |
| FQ3 2026 (Sep 2026) | 1.81B | -- | 1.78B | 1.84B | 4 |
| FQ2 2026 (Jun 2026) | 1.6B | -7.18 | 1.58B | 1.63B | 7 |
| FQ1 2026 (Mar 2026) | 1.69B | -0.51 | 1.66B | 1.72B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 3.6131 | 3.6131 | 100% | |
| FQ1 2025 (Mar 2025) | 2.07 | 2.07 | 100% | |
| FQ4 2024 (Dec 2024) | 4.76 | 4.76 | 100% | |
| FQ3 2024 (Sep 2024) | 2.36 | 2.36 | 100% | |
| FQ2 2024 (Jun 2024) | 2.67 | 2.67 | 100% | |
| FQ1 2024 (Mar 2024) | 1.41 | 1.41 | 100% | |
| FQ4 2023 (Dec 2023) | 4.26 | 4.26 | 100% | |
| FQ3 2023 (Jul 2023) | 2 | 2 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0B | $1.72B | $1719.1M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.7B | $1697.3M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $2.14B | $2143.5M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.73B | $1726M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.51B | $1512.2M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.57B | $1567.9M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.93B | $1934M | 100% |
| FQ3 2023 (Jul 2023) | $0B | $1.5B | $1496.5M | 100% |